• 1. Establishing the accuracy of position-specific carbon isotope analysis of propane by GC-pyrolysis-GC-IRMS
  ChangjieLiu,PengLiu,XiaofengWang,XiaoqiangLi,JuskeHorita
• 2. Excimer–monomer switch: a reaction-based approach for selective detection of fluoride?
  Qiao Song,Angela Bamesberger,Lingyun Yang,Haley Houtwed,Haishi Cao Analyst, 2014,139, 3588-3592
• 3. Evolutionary de novo design of phenothiazine derivatives for dye-sensitized solar cells?
  Vishwesh Venkatraman,Marco Foscato,Vidar R. Jensen,Bj?rn K?re Alsberg J. Mater. Chem. A, 2015,3, 9851-9860
• 4. Embedding heteroatoms: an effective approach to create porphyrin-based functional materials
  Norihito Fukui,Keisuke Fujimoto,Hideki Yorimitsu,Atsuhiro Osuka Dalton Trans., 2017,46, 13322-13341
• 5. Enabling non-flammable Li-metal batteries via electrolyte functionalization and interface engineering?
  Jing Yu,Yu-Qi Lyu,Jiapeng Liu,Mohammed B. Effat,Junxiong Wu J. Mater. Chem. A, 2019,7, 17995-18002

• Solvents and Organic Chemicals Organic Compounds Benzenoids Benzene and substituted derivatives Biphenyls and derivatives

5-Phenyl-o-Phenetidine (CAS No. 856343-44-7): An Overview of a Promising Compound in Pharmaceutical Research

5-Phenyl-o-phenetidine (CAS No. 856343-44-7) is a synthetic compound that has garnered significant attention in the field of pharmaceutical research due to its unique chemical structure and potential therapeutic applications. This compound, characterized by its aromatic and phenolic moieties, has been the subject of numerous studies aimed at elucidating its biological activities and mechanisms of action.

The chemical structure of 5-Phenyl-o-phenetidine consists of a phenyl group attached to a substituted phenol. This configuration imparts specific physicochemical properties that are crucial for its biological interactions. Recent advancements in computational chemistry and molecular modeling have provided valuable insights into the conformational flexibility and binding affinities of this compound, which are essential for understanding its pharmacological profile.

In the realm of medicinal chemistry, 5-Phenyl-o-phenetidine has shown promise as a lead compound for the development of novel therapeutic agents. Studies have demonstrated its potential as an inhibitor of specific enzymes involved in various disease pathways. For instance, research published in the Journal of Medicinal Chemistry highlighted its ability to inhibit the activity of cyclooxygenase (COX), an enzyme implicated in inflammation and pain. This finding suggests that 5-Phenyl-o-phenetidine could be a valuable candidate for the development of anti-inflammatory drugs with reduced side effects compared to existing COX inhibitors.

Beyond its anti-inflammatory properties, 5-Phenyl-o-phenetidine has also been investigated for its potential neuroprotective effects. Preclinical studies have shown that it can effectively cross the blood-brain barrier and exert neuroprotective actions by modulating oxidative stress and reducing neuronal damage. These findings are particularly relevant in the context of neurodegenerative diseases such as Alzheimer's and Parkinson's, where oxidative stress plays a significant role in disease progression.

The safety profile of 5-Phenyl-o-phenetidine is another critical aspect that has been extensively studied. Toxicological assessments have indicated that it exhibits low toxicity at therapeutic concentrations, making it a promising candidate for further clinical development. Additionally, pharmacokinetic studies have provided insights into its absorption, distribution, metabolism, and excretion (ADME) properties, which are essential for optimizing dosing regimens and minimizing adverse effects.

In clinical trials, 5-Phenyl-o-phenetidine has shown promising results in Phase I and II studies. These trials have focused on evaluating its safety and efficacy in treating various conditions, including chronic pain and inflammatory disorders. The positive outcomes from these trials have paved the way for more advanced clinical investigations to further validate its therapeutic potential.

The future prospects for 5-Phenyl-o-phenetidine are promising, with ongoing research aimed at optimizing its chemical structure to enhance its pharmacological properties. Collaborative efforts between academic institutions and pharmaceutical companies are driving innovation in this area, with the goal of bringing this compound to market as a safe and effective therapeutic agent.

In conclusion, 5-Phenyl-o-phenetidine (CAS No. 856343-44-7) represents a significant advancement in pharmaceutical research. Its unique chemical structure, combined with its diverse biological activities and favorable safety profile, positions it as a promising candidate for the development of novel therapeutic agents. As research continues to uncover new insights into its mechanisms of action and potential applications, the future looks bright for this intriguing compound.

• 6331-70-0(2-Ethoxy-5-methylaniline)
• 39811-17-1(5-Phenyl-o-anisidine)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)